Clinical trials
Not yet recruiting Respiratory Distress Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 11 |
| 2026 | 38 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 6 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 2 |
| Southeast University, China | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| University Hospital, Angers | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Aga Khan University | 1 |
| Asia Cell Therapeutics (Shanghai) Co., Ltd. | 1 |
| BioSpring Medical Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Distress Syndrome | 61 |
| Sepsis | 6 |
| Premature Birth | 5 |
| Critical Illness | 4 |
| Bronchopulmonary Dysplasia | 3 |
| Respiratory Insufficiency | 3 |
| Ventilator-Induced Lung Injury | 3 |
| Burns | 2 |
| Community-Acquired Pneumonia | 2 |
| Heart Failure | 2 |
Trials
Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.